Real World Patient-reported Outcomes in HIV-infected Adults Switching to EVIPLERA (R), Because of a Previous Intolerance to cART. PRO-STR Study

Autor: Podzamczer, D, Rozas, N, Domingo, P, Miralles, C, van den Eynde, E, Romero, A, Deig, E, Knobel, H, Pasquau, J, Antela, A, Clotet, B, Geijo, P, de Castro, ER, Casado, MA, Munoz, A, Casado, A, Palter, DP, Gonzalez, JS, Palacios, AR, Mayorga, MI, Liano, JP, Alfaro, EM, Sepulveda, MA, Yzusqui, M, Farre, JRB, Martinez, PG, Zapata, MR, Luque, PB, Carrasco, AB, Lorenzo, JF, Comerma, ED, Torrella, A, Serrano, XS, Lopez, AA, Alvarez, CM, Aren, JD, Fernandez, P, Hurtado, ERD

Publikováno v: Current HIV Research
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname

Background: To investigate the impact of switching from stable Combined Antiretroviml Therapy (cART) to single-tablet regimen (RPV/FTC/TDF=EVIPLERA (R) /COMPLERA (R)) on patient-reported outcomes in HIV-infected adults who cannot tolerate previous cA

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::72e96c4ba7cdb9ac87256d87deda7183
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=5781